Condition: Dyssynergia · Constipation · Sponsor: The California Medical Innovations Institute, Inc.
Constipation affects 12-19% of Americans. Pelvic floor dyssynergia is considered to play an important role in constipation but the underlying mechanisms are not well understood in individual patients. The investigators have developed a novel device named Fecobionics that provide detailed mapping of physiological parameters during defecation. The aim of the study is to use Fecobionics to assess anorectal function in dyssynergia patients and monitor and predict the outcome of the biofeedback therapy.
This description comes directly from the study's public registry record.
Hans Gregersen, PhD · 858-249-7400 · hag@giome.org
Satish Rao, MD, PhD · 706-7212238 · srao@augusta.edu
Always discuss trial participation with your own doctor first.
| California Medical Innovations Institute | San Diego, California, United States | Recruiting |
| Digestive Health Center- Augusta University | Augusta, Georgia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05807321